The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
AI资讯
Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
相关文章
AI资讯
ChatGPT mobile app gets voice-based agentic features
Pro and Plus users will be able to use the Work tab on their phones to complete ...
AI资讯
Snorkel AI triples valuation to $3.5B as demand for AI training data booms
The seven-year-old startup has raised a $350 million Series E to fuel its data-a...
AI资讯
Qualcomm launches two new smartphone chips with emphasis on AI
Qualcomm said that its new top chip can run 30B mixture-of-expert model locally....